Lymph node removal during prostate surgery: a comparison study
Part of Cancer, Kidney & urinary clinical trials.
This trial tests whether removing pelvic lymph nodes during prostate cancer surgery improves outcomes for men with high-risk prostate cancer. If you have high-risk prostate cancer and no signs of spread, you may be able to join.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 or older with a life expectancy over 15 years.
- You have high-risk prostate cancer confirmed by biopsy (grade group 3, 4, or 5, or grade group 2 with PSA over 20).
- Your PSMA-PET scan shows no cancer spread to lymph nodes or distant areas.
- You are healthy enough for surgery (WHO performance 0-1 and ASA score 3 or less).
- You have not had prior treatments like hormone therapy, radiation, or lymph node removal for prostate cancer.
- You have no other serious medical conditions that would interfere with treatment.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial compares two surgical approaches for removing lymph nodes during prostate cancer surgery in men with high-risk disease on one side of the prostate. The goal is to determine whether removing lymph nodes from both sides or just one side provides better outcomes.
This study looks at whether removing lymph nodes during prostate removal helps predict outcomes in men whose scans do not show spread. It may help improve how doctors decide who benefits from lymph node surgery based on your risk level and scan results.
This trial compares two types of lymph node removal during prostate cancer surgery to see if removing fewer lymph nodes is just as effective. It is for men with prostate cancer that has not spread beyond the pelvis.
This trial is testing whether a special scan (PSMA PET/CT) before surgery can help doctors decide if you need to remove lymph nodes. It is for men with high-risk prostate cancer who are already planning to have robot-assisted prostate removal.
This study tests whether a special prostate scan called PSMA PET/CT can help doctors decide which pelvic lymph nodes to remove during prostate surgery. It may improve who needs lymph node surgery by using scan results to guide the operation.
This trial compares radical prostatectomy (surgery to remove the prostate) alone versus surgery plus pelvic lymph node removal, with or without additional radiation, for men with intermediate- or high-risk prostate cancer that has not spread. It aims to see which approach is more effective and safe.
Hear when a new Prostate Cancer Surgery trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.